Efficacy of danazol with autoimmune thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 4, 1997, Pages 251-255

  Kim, Steven W ^a   Rice, Lawrence ^a,b   McCarthy, John J ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b MS 902 ^*  (United States)

Author keywords

Autoimmune thrombocytopenia; Danazol; Evans' syndrome; HIV; Idiopathic thrombocytopenic purpura; Systemic lupus erythematosus

Indexed keywords

DANAZOL;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; LIVER DYSFUNCTION; MALE; MASTALGIA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REMISSION; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WEIGHT GAIN;

EID: 0031410174     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969700300406     Document Type: Article

References (33)

1. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989;74:2309.
2. Karpatkin S. Autoimmune thrombocytopenia purpura. Blood 1980; 56:329.
3. Bussel JB. The use of intravenous gamma-globulin in idiopathic thrombocytopenia purpura. Clin Immunol & Immunopathol 1989;53(2 Pt 2):S147.
4. Boughton BJ, Chakraverty R, Baglin TP, et al. The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: Its effectiveness, safety and mechanism of action. Clin Lab Haematol 1988;10:275.
5. Snyder HW Jr, Cochran SK, Balint JP Jr, et al. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 1992;79:2237.
6. Ahn YS, Harrington WJ, Simon SR, et al. Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983; 308:1396.
7. Ahn YS. Efficacy of danazol in hematologic disorders. Acta Haematol 1990;84:122.
8. McVerry BA, Auger M, Bellingham AJ. The use of danazol in the management of chronic immune thrombocytopenic purpura. Br J Haematol 1985;61:145.
9. Heyd J, Hershko C. Use of danazol in the management of chronic idiopathic thrombocytopenia purpura, Isr J Med Sci 1985;21:418.
10. Buelli M, Cortelazzo S, Viero P, et al. Danazol for the treatment of idiopathic thrombocytopenic purpura. Acta Haematol 1985;74:97.
11. Ambriz R, Pizzuto J, Morales M, et al. Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocytopenic purpura (immune thrombocytopenic purpura). Nouv Rev Fr Hematol 1986;28:275.
12. Ahn YS, Mylvaganam R, Garcia RO, et al. Low-dose danazol therapy in idiopathic thrombocytopenic purpura. Ann Intern Med 1987;107:177.
13. Manoharan A. Danazol therapy in patients with immune cytopenias. Aust NZ J Med 1987;17:613.
14. Schreiber AD, Chien P, Tomaski A, et al. Effect of danazol in immune thrombocytopenic purpura. N Engl J Med 1987;316:503.
15. Kotlarek-Haus S, Pdolak-Dawidziak M. Danazol in chronic idiopathic thromboctopenic purpura resistant to corticosteroids. Folia Haematol 1987;114:768.
16. Mazzuconi MG, Francesconi M, Falcione E, et al. Danazol therapy in refractory chronic immune thrombocytopenic purpura. Acta Haematol 1987;77:45.
17. Weinblatt ME, Kochen J, Ortega J. Danazol for children with immune thrombocytopenic purpura. Am J Dis Child 1988;142: 1317.
18. Ahn YS, Rocha R, Mylvaganam R, et al. Long-term danazol therapy in autoimmune thrombocytopenia: Unmaintained remission and age-dependent response in women. Ann Intent Med 1989; 111:723.
19. Edelmann DZ, Knobel B, Virag I, et al. Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura. Postgrad Med J 1990;66:827.
20. Flores A, Carles J, Junca J, et al. Danazol therapy in chronic immune thrombocytopenic purpura. Eur J Haematol 1990;45:109.
21. Donaldson V. Danazol. Am J Med 1989;87:49N.
22. Ahn YS. Efficacy of danazol in hematologic disorders. Acta Haematol 1990;84:122.
23. Stadtmauer EA, Cassileth PA, Edelstein M, et al. Danazol treatment in myelodysplastic syndromes. Br J Haematol 1991;77:502.
24. Temple JD, Harrington WJ, Ahn YS, et al. Treatment of sickle cell disease with danazol. J Fla Med Assoc 1986;73:847.
25. Harrington WJ, Ahn YS, Cohen JJ, et al. Treatment of paroxysmal nocturnal hemoglobinuria with danazol [Abstract]. Blood 1984; 64:86.
26. Mylvaganam R, Ahn YS, Garcia RO, et al. Very low dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator. Am J Med Sci 1989;298:215.
27. Furubayashi T, Mizutani H, Take H, et al. Impaired suppressor function of T cells induced by autologous mixed lymphocyte reaction in patients with idiopathic thrombocytopenic purpura. Acta Haematol 1992;87:32.
28. Horstman LL, Wenche J, Manuel A, et al. Danazol distribution in plasma and cell membranes as related to altered cell properties. Am J Hematol 1995;50:179.
29. Friedman D, Nettl F, Schrieber AD. Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes. J Clin Invest 1985;75:162.
30. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for The American Society of Hematology. Blood 1996;88:3.
31. Marion K, Cook P. Danazol for lupus thrombocytopenia. Arch Intern Med 1985;145;2251.
32. Koike M, Ishiyama T, Saito K, et al. Effective danazol therapy for a patient with Evans' syndrome. Rinsho Ketsueki 1993;34:143.
33. Rabinowitz AP, Sacks Y, Carmel R. Autoimmune cytopenias in pernicious anemia: A report of four cases and review of the literature. Eur J Haematol 1990;44:18.